3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colorectal Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Tuberous Sclerosis
1
Thyroid Neoplasms
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Pheochromocytoma
1
Paraganglioma
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphangioleiomyomatosis
1
Kidney Neoplasms
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
HER2-positive Breast Cancer
1
Glioma
1
Early Detection of Cancer
1
Breast Carcinoma In Situ
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
mitazalimab
1
irinotecan sucrosofate
1
Tissue Banks
1
Specimen Handling
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Irinotecan
1
Glucose
1
Genetic Testing
1
Gemcitabine
1
Fluorouracil
1
Contrast Media
1
Capecitabine
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pancreatic Ductal Adenocarcinoma
×
Genetic Testing
×
Clear all
NCT06574620
2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA
Recruiting
200 enrolled